HOLD
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research.

We would consider results OK. Cash flow per share of 16c did miss estimates of 17c, but revenue of $135M beat estimates of $122M. Payout ratio has risen but on an annual basis was 68% in 2022. Operating income increased, offset by higher rates.  Occupancy is good at 97%, leases are long and many are indexed. The convertible issue, the institutional investor and the planned asset sales should add a lot more financial flexibility. The proof will be in the pudding but the comments we think make the point that management knows that leverage and recession concerns are hurting their valuation. We are not sure the corned has been turned, but are more optimistic than pessimistic, largely because of its already-low valuation. 
Unlock Premium - Try 5i Free

REAL ESTATE
SELL

Heading down and continues to make new lows. Moving opposite to the TSX, which has turned and is heading higher. Lower lows and lower highs, the definition of a downtrend. Sell your losers.

REAL ESTATE
WATCH
Add now?

Tough. Heavy debt load with variable rate exposure. Good business. Reworking portfolio. Should be stable once they right-size balance sheet, which they're working on. He's watching it. He's not tempted to bottom-fish, wants to see a few better quarters first.

REAL ESTATE
DON'T BUY

Global assets. In a tough spot. Challenges to earnings from interest rates and currency. Great assets. Not for the faint of heart. Not for him today.

REAL ESTATE
DON'T BUY

It owns medical facilities globally. This includes medical office buildings, hospitals, etc. The balance sheet is a bit stretched along with an 8% yield. Another concern is some cash flow disruption due to not hedging currencies.

REAL ESTATE
COMMENT
(NWH does not operate retirement homes.) Rather, they operate hospitals and medical buildings across Canada, Europe, Brazil and Australia. So, they take on currency risk. Their large growth has been financed by variable-rate debt, because NWH felt that these properties could be put into joint ventures--take that JV capital and continues to grow with it, then turn out that debt at that time. The rapid spike in interest rates has caught them off guard. So, they have more risk than the typical. Pays a higher yield, but at a higher payout ratio. Their assets are quality, many being infrastructure.
REAL ESTATE
TOP PICK
High dividend yield (~8%). Current share price presenting good buying opportunity (long term investor). Healthcare properties not sensitive to rising interest rates. Well managed and consistent growth.
REAL ESTATE
DON'T BUY
Its assets are a fantastic way to earn on real estate. Geographically diversified with multiple management teams and dynamics, so it's hard to wrap your head around. Outperformed relative to the sector. He prefers a simpler theme.
REAL ESTATE
BUY ON WEAKNESS
Global medical facilities. Canada, Brazil, Australia, UK, Europe. Shares sold off with failed Australian deal. Stable operator. Premium to NAV. Yield is safe. Bit of currency volatility. Grows nicely, in good shape. Issues equity to fund growth, which provides a time to buy.
REAL ESTATE
BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. NAV per unit growth is 6.3% based on strong revaluation gains in Australia and a rebound for Brazilian Real. The growth strategy based on continued revaluation gains and execution in UK value creation initiatives was reiterated by management. Deploying capital for their acquisition. A fine quarter. Unlock Premium - Try 5i Free

REAL ESTATE
WAIT
It's recovered. Trades at a premium to NAV, so they can continue to expand globally and issue debt to do so. Most assets outside Canada. Wait for pullback, probably later this year if they raise equity to close current acquisition in Australia.
REAL ESTATE
WEAK BUY
A diversified healthcare REIT, with assets in Australia, New Zealand, UK, Brazil and Canada. They just issued units to the public, which signals their stock is fairly valued. It trades at a discount to NAV. NWH is very safe, operating in the right segments of healthcare. They have a growing asset management business, providing steady a fee income stream. There's less upside here vs. other healthcare names, and you're owning for the yield.
REAL ESTATE
HOLD
Right area of healthcare. Global footprint. Trades at a premium. As they continue to acquire assets, they should be in a good spot. If you own it, continue to hold.
REAL ESTATE
BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. A very decent REIT. They have a stable base of business with good income. Not cheap on valuation but the last quarter results were good and it has weathered the pandemic well. Unlock Premium - Try 5i Free

REAL ESTATE
COMMENT
Owns hospitals, medical office buildings. Global. Likes the industry. Fair valuation. High leverage. Dividend's flat and barely covered. Earnings volatile. See top picks for her preferred name.
REAL ESTATE
Showing 1 to 15 of 100 entries

NorthWest Health Prop Real Est Inv Trust(NWH.UN-T) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 1

Bearish - Sell Signals / Votes : 4

Total Signals / Votes : 5

Stockchase rating for NorthWest Health Prop Real Est Inv Trust is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

NorthWest Health Prop Real Est Inv Trust(NWH.UN-T) Frequently Asked Questions

What is NorthWest Health Prop Real Est Inv Trust stock symbol?

NorthWest Health Prop Real Est Inv Trust is a Canadian stock, trading under the symbol NWH.UN-T on the Toronto Stock Exchange (NWH.UN-CT). It is usually referred to as TSX:NWH.UN or NWH.UN-T

Is NorthWest Health Prop Real Est Inv Trust a buy or a sell?

In the last year, 5 stock analysts published opinions about NWH.UN-T. 0 analysts recommended to BUY the stock. 4 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for NorthWest Health Prop Real Est Inv Trust.

Is NorthWest Health Prop Real Est Inv Trust a good investment or a top pick?

NorthWest Health Prop Real Est Inv Trust was recommended as a Top Pick by on . Read the latest stock experts ratings for NorthWest Health Prop Real Est Inv Trust.

Why is NorthWest Health Prop Real Est Inv Trust stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is NorthWest Health Prop Real Est Inv Trust worth watching?

5 stock analysts on Stockchase covered NorthWest Health Prop Real Est Inv Trust In the last year. It is a trending stock that is worth watching.

What is NorthWest Health Prop Real Est Inv Trust stock price?

On 2023-05-31, NorthWest Health Prop Real Est Inv Trust (NWH.UN-T) stock closed at a price of $7.48.